Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-03-23
1996-02-13
Datlow, Philip I.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514252, 514256, 514365, 514374, 514397, 514406, 514422, 514431, 514432, 514443, 514450, 514456, 514459, 514469, 544333, 544405, 546268, 548204, 548236, 5483151, 5483657, 548561, 5483111, 549 9, 549 13, 549 23, 549 28, 549 57, 549 58, 549355, 549397, 549401, 549425, 549463, 549467, 549 72, 549346, 549487, A61K 3138, A61K 3144, C07D40512, C07D40912
Patent
active
054911524
ABSTRACT:
The present invention provides compounds of Formula I, ##STR1## or a pharmaceutically acceptable salt forms thereof, which are inhibitors of acyl-Coenzyme A: cholesterol O-acyltransferase (ACAT), pharmaceutical compositions containing such compounds, processes for the preparation of such compounds, and the use of such compounds as antihypercholesterolemic and/or antiatherosclerotic agents.
REFERENCES:
patent: 4623662 (1986-11-01), DeVries
patent: 4722927 (1988-02-01), Holmes
patent: 4824843 (1989-04-01), Hoefle et al.
patent: 4868210 (1989-09-01), Trivedi
patent: 4882357 (1989-11-01), Creger et al.
patent: 4900744 (1990-02-01), Billheimer et al.
Pfeifer et al, Tetrahedron Letters, 31 (40), pp. 5725-5728 (1990).
Kirby et al, J. Chem. Soc. Chem. Comm. (14), pp. 922-923 (1984).
Billheimer Jeffrey T.
Ko Soo S.
Wilde Richard G.
Datlow Philip I.
Ferguson Blair Q.
Kondrad Karen H.
The Du Pont Merck Pharmaceutical Company
LandOfFree
Derivatives of cyclic ethers and sulfides for the treatment of a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of cyclic ethers and sulfides for the treatment of a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of cyclic ethers and sulfides for the treatment of a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-240820